SEC Comment Letter for 9 METERS BIOPHARMA, INC. (NMTRQ) (CIK 0001551986) — Sep 3, 2020

9 METERS BIOPHARMA, INC. (NMTRQ) (CIK 0001551986)
Date: Sept. 3, 2020 · CIK: 0001551986 · Accession: 0000000000-20-008329

View on Edgar

AI Filing Summary & Sentiment

File numbers found in text: 001-37797

Date

September 3, 2020

Author

Not clearly detected

Form

UPLOAD

Company

9 METERS BIOPHARMA, INC. (NMTRQ) (CIK 0001551986)

Letter

United States securities and exchange commission logo September 3, 2020 Edward Sitar Chief Financial Officer 9 Meters Biopharma, Inc. 8480 Honeycutt Road, Suite 120 Raleigh, North Carolina 27615 Re:9 Meters Biopharma, Inc. Form 10-Q for Fiscal Quarter Ended June 30, 2020 Filed August 13, 2020 File No. 001-37797 Dear Mr. Sitar: We have completed our review of your filing. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Sincerely, Division of Corporation Finance Office of Life Sciences

Show Raw Text

United States securities and exchange commission logo
September 3, 2020
Edward Sitar
Chief Financial Officer
9 Meters Biopharma, Inc.
8480 Honeycutt Road, Suite 120
Raleigh, North Carolina 27615
Re:9 Meters Biopharma, Inc.
Form 10-Q for Fiscal Quarter Ended June 30, 2020
Filed August 13, 2020
File No. 001-37797
Dear Mr. Sitar:
            We have completed our review of your filing.  We remind you that the company and its
management are responsible for the accuracy and adequacy of their disclosures, notwithstanding
any review, comments, action or absence of action by the staff.
Sincerely,
Division of Corporation Finance
Office of Life Sciences

SecProbe.io